BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 28, 2000
View Archived Issues
Ares-Serono advances global R&D program during 1999
Read More
Bristol-Myers Squibb reaches significant milestones during 1999
Read More
Celltech Chiroscience and Medeva finalize merger
Read More
FDA approves new labeling for Hyalgan
Read More
Taisho and Takeda to collaborate internationally
Read More
Immunomedics reports clinical findings for cancer therapeutic
Read More
New formulation of Xatral receives European approvals
Read More
Avant and WRAIR to collaborate on HIV vaccine development
Read More
Newly issued U.S. patent protects Inhale's dry powder DNA formulations
Read More
Immunomedics issued new patent for radioimmunodetection and radioimmunotherapy applications
Read More
Beclomethasone Clickhaler approved in France
Read More
Carbapenems substituted at the 2-position active against resistant Gram-positive bacteria
Read More
Analgesic 1,4-substituted cyclohexyl compounds in development at AstraZeneca
Read More
ReVele effectively detects GRP-positive tumors in phase II trial
Read More
Licensing opportunity from NIH: 5-lipoxygenase inhibitors as anticancer agents
Read More
Neuropharmacological profile of NRA-0160, a unique antipsychotic drug candidate
Read More
MCC-134 activates or inhibits K(ATP) channel currrents in a SUR subtype-dependent manner
Read More
OPERA will evaluate morbidity and mortality benefits of omapatrilat in at-risk patients
Read More
OPC-14523 selected for clinical development as potential antidepressant
Read More
Pharmacia selected as name for new company formed by P&U-Monsanto merger
Read More
Intranasal IL-12 is a potent adjuvant for enhancing antiviral immunity
Read More
American Biogenetic Sciences licenses worldwide rights for ABS-103 to Abbott
Read More
Two new anticancer human MAbs enter development at AVI BioPharma
Read More
Schering-Plough seeks E.U. approval of Caelyx for treatment of advanced ovarian cancer
Read More
Studies at DuPont suggest clinical utility of SF-303 and SK-549 as novel antithrombotics
Read More
SciClone initiates phase II study of Zadaxin in hepatitis B
Read More
Gene-based osteoarthritis collaboration initiated by Quark and Shionogi
Read More
Commencement of clinical trials of Altropane for ADHD diagnosis imminent
Read More